India's bioeconomy has experienced significant growth, increasing from USD 166 billion in 2024 to USD 195 billion in 2025. This expansion is driven by diverse industries including biopharmaceuticals ...

Discover how CRISPR genome editing is revolutionizing medicine. Learn the science of Cas9, current clinical trials, and the future of gene editing.

The Minister credited BIRAC as a key catalyst in translating scientific research into commercially viable products.

While the deal makes strategic sense, integrating two distinct businesses and delivering profitability ahead of a potential ...

Scientists at MIT and Stanford have unveiled a promising new way to help the immune system recognize and attack cancer cells more effectively. Their strategy targets a hidden “off switch” that tumors ...

New research-use-only materials platform reinforces verified researcher access, documentation standards, and laboratory handling protocols Sebastopol, California— February 26, 2026 — BiotechLabzSupply ...

Subscribe Login Register Log out My Profile Subscriber Services Search PGe NEWSLETTERS PG STORE ARCHIVES PUBLIC NOTICES OBITUARIES JOBS CLASSIFIEDS EVENTS PETS ...

When GSK’s new CEO Luke Miels told investors last month that “smart business development” is a key pillar for his strategy, he wasn’t lying. The British Big Pharma has just announced its second ...

Vir Biotechnology might be on its way to becoming a major player in the market for cancer drugs if Tuesday’s stock reaction is any indication.

Shares of Arcellx, a mid-cap drug developer, headed for their best day on record Monday after Gilead Sciences agreed to buy it in a deal worth $7.8 billion.

NEW YORK CITY, NY AND MACAU, CHINA / ACCESS Newswire / February 23, 2026 / CL Workshop Group Limited (the "Company") (Nasdaq:NWGL), a global leading vertically-integrated forestry company ...